Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma. Cabalag CS, Yates M, Corrales MB, Yeh P, et al. Ann Surg 2022;276:e120-e126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cabalag CS, Yates M, Corrales MB, Yeh P, et al. Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma. Ann Surg 2022;276:e120-e126.
PMID: 35737908